{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:25:58Z","timestamp":1758043558346,"version":"3.44.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFA1103300","2022YFA1103300"],"award-info":[{"award-number":["2022YFA1103300","2022YFA1103300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical and Translational Medicine Research Project of Chinese Academy of Medical Sciences","award":["2023-I2M-C&T-B-107","2023-I2M-C&T-B-107"],"award-info":[{"award-number":["2023-I2M-C&T-B-107","2023-I2M-C&T-B-107"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370142","82370142"],"award-info":[{"award-number":["82370142","82370142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00277-025-06393-z","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T07:19:31Z","timestamp":1754551171000},"page":"3981-3992","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Somatic mutations and the efficacy of immunosuppressive therapy in severe\/very severe aplastic anemia and transfusion-dependent nonsevere aplastic anemia"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6615-9573","authenticated-orcid":false,"given":"Lei","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donglei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youzhen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meili","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengkui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"6393_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0140-6736(04)16724-X","volume":"364","author":"AM Risitano","year":"2004","unstructured":"Risitano AM, Maciejewski JP, Green S, Plasilova M, Zeng W, Young NS (2004) In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet 364:355\u2013364. https:\/\/doi.org\/10.1016\/S0140-6736(04)16724-X","journal-title":"Lancet"},{"key":"6393_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","volume":"147","author":"JC Marsh","year":"2009","unstructured":"Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, Keidan J, Laurie A, Martin A, Mercieca J, Killick SB, Stewart R, Yin JA, British Committee for Standards in Haematology (2009) British committee for standards in haematology. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 147:43\u201370. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07842.x","journal-title":"Br J Haematol"},{"key":"6393_CR3","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1182\/blood-2010-08-304071","volume":"117","author":"A Tichelli","year":"2011","unstructured":"Tichelli A, Schrezenmeier H, Socie \u0301 G, Marsh J, Bacigalupo A, D\u00fchrsen U, Franzke A, Hallek M, Thiel E, Wilhelm M, H\u00f6chsmann B, Barrois A, Champion K, Passweg JR (2011) A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte Globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA working party of the European group for blood and marrow transplantation. Blood 117:4434\u20134441. https:\/\/doi.org\/10.1182\/blood-2010-08-304071","journal-title":"Blood"},{"key":"6393_CR4","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1182\/blood-2013-09-381665","volume":"122","author":"M Cazzola","year":"2013","unstructured":"Cazzola M, Della Porta MG, Malcovati L (2013) The genetic basis of myelodysplasia and its clinical relevance. Blood 122:4021\u20134034. https:\/\/doi.org\/10.1182\/blood-2013-09-381665","journal-title":"Blood"},{"key":"6393_CR5","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck DB, Ferrada MA, Sikora KA et al (2020) Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med 383:2628\u20132638. https:\/\/doi.org\/10.1056\/NEJMoa2026834","journal-title":"N Engl J Med"},{"key":"6393_CR6","doi-asserted-by":"publisher","first-page":"1365614","DOI":"10.3389\/fonc.2024.1365614","volume":"14","author":"N Kim","year":"2024","unstructured":"Kim N, Choi YJ, Lee ST, Choi JR, Lyu CJ, Shin S, Cheong JW (2024) Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights. Front Oncol 14:1365614. https:\/\/doi.org\/10.3389\/fonc.2024.1365614","journal-title":"Front Oncol"},{"key":"6393_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1414799","volume":"373","author":"T Yoshizato","year":"2015","unstructured":"Yoshizato T, Dumitriu B, Hosokawa K (2015) Somatic mutations and clonal hematopoiesis in aplastic anemia. N Engl J Med 373:35\u201347. https:\/\/doi.org\/10.1056\/NEJMoa1414799","journal-title":"N Engl J Med"},{"key":"6393_CR8","doi-asserted-by":"publisher","unstructured":"Huang J, Ge M, Lu S, Shi J, Li X, Zhang J, Wang M, Yu W, Shao Y, Huang Z, Zhang J, Nie N, Zheng Y (2015) Mutations of ASXL1 and TET2 in aplastic anemia. Haematologica 100:e172-5. https:\/\/doi.org\/10.3324\/haematol.2014.120931","DOI":"10.3324\/haematol.2014.120931"},{"key":"6393_CR9","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/ejh.13153","volume":"101","author":"RM Shallis","year":"2018","unstructured":"Shallis RM, Ahmad R, Zeidan AM (2018) Aplastic anemia: etiology, molecular pathogenesis, and emerging con- cepts. Eur J Haematol 101:711\u2013720. https:\/\/doi.org\/10.1111\/ejh.13153","journal-title":"Eur J Haematol"},{"key":"6393_CR10","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.12998\/wjcc.v11.i28.6908","volume":"36","author":"EM Groarke","year":"2022","unstructured":"Groarke EM, Patel BA, Shalhoub R (2022) Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia. Leuk 36:2328\u20132337. https:\/\/doi.org\/10.12998\/wjcc.v11.i28.6908","journal-title":"anemia Leuk"},{"key":"6393_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJMe2118143","volume":"386","author":"P Scheinberg","year":"2022","unstructured":"Scheinberg P (2022) A new standard immunosuppression regimen in severe aplastic anemia. N Engl J Med 386:89\u201390","journal-title":"N Engl J Med"},{"key":"6393_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2109965","volume":"386","author":"LR Peffault","year":"2022","unstructured":"Peffault LR, Kulasekararaj A, Iacobelli S et al (2022) Eltrombopag added to immunosuppression in severe aplastic anemia. N Engl J Med 386:11\u201323. https:\/\/doi.org\/10.1056\/NEJMoa2109965","journal-title":"N Engl J Med"},{"key":"6393_CR13","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1007\/s10238-023-01067-4","volume":"23","author":"L Liu","year":"2023","unstructured":"Liu L, Zhang D, Fu Q, Wang J, Yu J, Chen D, Wang F, Guo R, Xie X, Jiang Z, Li Y (2023) Clinical implications of myeloid malignancy-related somatic mutations in aplastic anemia. Clin Exp Med 23:4473\u20134482. https:\/\/doi.org\/10.1007\/s10238-023-01067-4","journal-title":"Clin Exp Med"},{"key":"6393_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/bjh.14691","volume":"178","author":"HS Park","year":"2017","unstructured":"Park HS, Park SN, Im K, Kim SM, Kim JA, Hwang SM, Lee DS (2017) Telomere length and somatic mutations in correlation with response to immunosuppressive treatment in aplastic anaemia. Br J Haematol 178:603\u2013615. https:\/\/doi.org\/10.1111\/bjh.14691","journal-title":"Br J Haematol"},{"key":"6393_CR15","unstructured":"Shaffer LG, McGowan-Jordan J, Schmid M (2013) ISCN 2013: An International System for Human Cytogenetic Nomenclature (2013). Karger Medical and Scientific Publishers, KARGER. https:\/\/www.karger.com\/Book\/Home\/257302"},{"key":"6393_CR16","doi-asserted-by":"crossref","unstructured":"Hermann H, By the International Agranulocytosis and Aplastic Anemia Study (1987) Incidence of aplastic anemia: the relevance of diagnostic criteria. By the international agranulocytosis and aplastic anemia study. Blood 70:1718\u20131721","DOI":"10.1182\/blood.V70.6.1718.1718"},{"key":"6393_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1182\/blood.V45.3.355.355","volume":"45","author":"BM Camitta","year":"1975","unstructured":"Camitta BM, Rappeport JM, Parkman R, Nathan DG (1975) Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood 45:355\u2013363","journal-title":"Blood"},{"key":"6393_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2141.1988.tb02460.x","volume":"70","author":"A Bacigalupo","year":"1988","unstructured":"Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, Van Lint MT, Congiu M, De Planque MM, Ernst P, McCann S et al (1988) Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol 70:177\u2013182. https:\/\/doi.org\/10.1111\/j.1365-2141.1988.tb02460.x","journal-title":"Br J Haematol"},{"key":"6393_CR19","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/jama.289.9.1130","volume":"289","author":"S Rosenfeld","year":"2003","unstructured":"Rosenfeld S, Follmann D, Nunez O, Young NS (2003) Antithymocyte Globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 289:1130\u20131135. https:\/\/doi.org\/10.1001\/jama.289.9.1130","journal-title":"JAMA"},{"key":"6393_CR20","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.1038\/ncomms8686","volume":"6","author":"M Sausen","year":"2015","unstructured":"Sausen M, Phallen J, Adleff V, Jones S, Leary RJ, Barrett MT, Anagnostou V, Parpart-Li S, Murphy D, Kay Li Q, Hruban CA, Scharpf R, White JR, O\u2019Dwyer PJ, Allen PJ, Eshleman JR, Thompson CB, Klimstra DS, Linehan DC, Maitra A, Hruban RH, Diaz LA Jr, Von Hoff DD, Johansen JS, Drebin JA, Velculescu VE (2015) Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Nat Commun 6:7686. https:\/\/doi.org\/10.1038\/ncomms8686","journal-title":"Nat Commun"},{"key":"6393_CR21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1200\/EDBK_175397","volume":"37","author":"M Haider","year":"2017","unstructured":"Haider M, Duncavage EJ, Afaneh KF, Bejar R, List AF (2017) New insight into the biology, risk stratification, and targeted treatment of myelodysplastic syndromes. AM Soc Clin Oncol Educ Book 37:480\u2013494. https:\/\/doi.org\/10.1200\/EDBK_175397","journal-title":"AM Soc Clin Oncol Educ Book"},{"key":"6393_CR22","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/leu.2013.30","volume":"27","author":"AA Lane","year":"2013","unstructured":"Lane AA, Odejide O, Kopp N, Kim S, Yoda A, Erlich R, Wagle N, Abel GA, Rodig SJ, Antin JH, Weinstock DM (2013) Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia. Leukemia 27:968\u2013971. https:\/\/doi.org\/10.1038\/leu.2013.30","journal-title":"Leukemia"},{"key":"6393_CR23","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.3324\/haematol.2013.101642","volume":"99","author":"M Heuser","year":"2014","unstructured":"Heuser M, Schlarmann C, Dobbernack V, Panagiota V, Wiehlmann L, Walter C, Beier F, Ziegler P, Yun H, Kade S, Kirchner A, Huang L, Koenecke C, Eder M, Br\u00fcmmendorf TH, Dugas M, Ganser A, Thol F (2014) Genetic characterization of acquired aplastic anemia by targeted sequencing. Haematologica 99:e165\u2013e167. https:\/\/doi.org\/10.3324\/haematol.2013.101642","journal-title":"Haematologica"},{"key":"6393_CR24","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1182\/blood-2014-05-574889","volume":"124","author":"AG Kulasekararaj","year":"2014","unstructured":"Kulasekararaj AG, Jiang J, Smith AE, Mohamedali AM, Mian S, Gandhi S, Gaken J, Czepulkowski B, Marsh JC, Mufti GJ (2014) Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. Blood 124:2698\u20132704. https:\/\/doi.org\/10.1182\/blood-2014-05-574889","journal-title":"Blood"},{"key":"6393_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cancergen.2015.01.007","volume":"208","author":"DV Babushok","year":"2015","unstructured":"Babushok DV, Perdigones N, Perin JC, Olson TS, Ye W, Roth JJ, Lind C, Cattier C, Li Y, Hartung H, Paessler ME, Frank DM, Xie HM, Cross S, Cockroft JD, Podsakoff GM, Monos D, Biegel JA, Mason PJ, Bessler M (2015) Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia. Cancer Genet 208:115\u2013128. https:\/\/doi.org\/10.1016\/j.cancergen.2015.01.007","journal-title":"Cancer Genet"},{"key":"6393_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1182\/blood-2016-01-636381","volume":"128","author":"S Ogawa","year":"2016","unstructured":"Ogawa S (2016) Clonal hematopoiesis in acquired aplastic anemia. Blood 128:337\u2013347. https:\/\/doi.org\/10.1182\/blood-2016-01-636381","journal-title":"Blood"},{"key":"6393_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","volume":"130","author":"F Zink","year":"2017","unstructured":"Zink F, Stacey SN, Norddahl GL, Frigge ML, Magnusson OT, Jonsdottir I, Thorgeirsson TE, Sigurdsson A, Gudjonsson SA, Gudmundsson J, Jonasson JG, Tryggvadottir L, Jonsson T, Helgason A, Gylfason A, Sulem P, Rafnar T, Thorsteinsdottir U, Gudbjartsson DF, Masson G, Kong A, Stefansson K (2017) Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood 130:742\u2013752. https:\/\/doi.org\/10.1182\/blood-2017-02-769869","journal-title":"Blood"},{"key":"6393_CR28","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, Lindsley RC, Mermel CH, Burtt N, Chavez A, Higgins JM, Moltchanov V, Kuo FC, Kluk MJ, Henderson B, Kinnunen L, Koistinen HA, Ladenvall C, Getz G, Correa A, Banahan BF, Gabriel S, Kathiresan S, Stringham HM, McCarthy MI, Boehnke M, Tuomilehto J, Haiman C, Groop L, Atzmon G, Wilson JG, Neuberg D, Altshuler D, Ebert BL (2014) Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 371:2488\u20132498. https:\/\/doi.org\/10.1056\/NEJMoa1408617","journal-title":"N Engl J Med"},{"key":"6393_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/leu.2013.336","volume":"28","author":"T Haferlach","year":"2014","unstructured":"Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, Schnittger S, Sanada M, Kon A, Alpermann T, Yoshida K, Roller A, Nadarajah N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler HP, Klein HU, Dugas M, Aburatani H, Kohlmann A, Miyano S, Haferlach C, Kern W, Ogawa S (2014) Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 28:241\u2013247. https:\/\/doi.org\/10.1038\/leu.2013.336","journal-title":"Leukemia"},{"key":"6393_CR30","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1182\/blood.V79.6.1385.1385","volume":"79","author":"NS Young","year":"1992","unstructured":"Young NS (1992) The problem of clonality in aplastic anemia: Dr Dameshek\u2019s riddle, restated. Blood 79:1385\u20131392","journal-title":"Blood"},{"key":"6393_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-022-04786-y","volume":"606","author":"E Mitchell","year":"2022","unstructured":"Mitchell E, Spencer Chapman M, Williams N, Dawson KJ, Mende N, Calderbank EF, Jung H, Mitchell T, Coorens TH, Spencer DH, Machado H (2022) Clonal dynamics of haematopoiesis across the human lifespan. Nature 606:343\u2013350. https:\/\/doi.org\/10.1038\/s41586-022-04786-y","journal-title":"Nature"},{"key":"6393_CR32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41586-022-04618-z","volume":"604","author":"A Cagan","year":"2022","unstructured":"Cagan A, Baez-Ortega A, Brzozowska N, Abascal F, Coorens THH, Sanders MA, Lawson AR, Harvey LM, Bhosle S, Jones D, Alcantara RE (2022) Somatic mutation rates scale with lifespan across mammals. Nature 604:517\u2013524. https:\/\/doi.org\/10.1038\/s41586-022-04618-z","journal-title":"Nature"},{"key":"6393_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1200\/JCO.22.00710","volume":"41","author":"C Gurnari","year":"2023","unstructured":"Gurnari C, Pagliuca S, Prata PH, Galimard JE, Catto LFB, Larcher L, Sebert M, Allain V, Patel BJ, Durmaz A, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Caillat-Zucman S, Clappier E, Sicre de Fontbrune F, Voso MT, Visconte V, de Peffault R, Soulier J, Calado RT, Soci\u00e9 G, Maciejewski JP (2023) Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria. J Clin Oncol 41:132\u2013142. https:\/\/doi.org\/10.1200\/JCO.22.00710","journal-title":"J Clin Oncol"},{"key":"6393_CR34","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jama.2010.1376","volume":"304","author":"P Scheinberg","year":"2010","unstructured":"Scheinberg P, Cooper JN, Sloand EM, Wu CO, Calado RT, Young NS (2010) Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia. JAMA 304:1358\u20131364. https:\/\/doi.org\/10.1001\/jama.2010.1376","journal-title":"JAMA"},{"key":"6393_CR35","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1182\/blood.2019000991","volume":"136","author":"JT Warren","year":"2020","unstructured":"Warren JT, Link DC (2020) Clonal hematopoiesis and risk for hematologic malignancy. Blood 136:1599\u20131605. https:\/\/doi.org\/10.1182\/blood.2019000991","journal-title":"Blood"},{"key":"6393_CR36","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","volume":"52","author":"KL Bolton","year":"2020","unstructured":"Bolton KL, Ptashkin RN, Gao T, Braunstein L, Devlin SM, Kelly D, Patel M, Berthon A, Syed A, Yabe M, Coombs CC (2020) Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat Genet 52:1219\u20131226. https:\/\/doi.org\/10.1038\/s41588-020-00710-0","journal-title":"Nat Genet"},{"key":"6393_CR37","doi-asserted-by":"publisher","first-page":"14566","DOI":"10.1073\/pnas.1112317108","volume":"108","author":"M Ko","year":"2011","unstructured":"Ko M, Bandukwala HS, An J, Lamperti ED, Thompson EC, Hastie R, Tsangaratou A, Rajewsky K, Koralov SB, Rao A (2011) Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc Natl Acad Sci 108:14566\u201314571. https:\/\/doi.org\/10.1073\/pnas.1112317108","journal-title":"Proc Natl Acad Sci"},{"key":"6393_CR38","doi-asserted-by":"crossref","unstructured":"Challen GA, Sun D, Jeong M, Luo M, Jelinek J, Berg JS, Bock C, Vasanthakumar A, Gu H, Xi Y, Liang S (2011) Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 44:23\u201331. https:\/\/doi,org10.1038\/ng.1009","DOI":"10.1038\/ng.1009"},{"key":"6393_CR39","doi-asserted-by":"publisher","unstructured":"Weeks LD, Niroula A, Neuberg DS, Wong WJ, Lindsley RC, Luskin MR, Berliner N, Stone RM, DeAngelo DJ, Soiffer RJ, Uddin MM (2023) Prediction of risk for myeloid malignancy in clonal hematopoiesis. NEJM Evid 2. https:\/\/doi.org\/10.1056\/evidoa2200310","DOI":"10.1056\/evidoa2200310"},{"key":"6393_CR40","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1182\/blood.v99.9.3129","volume":"99","author":"JP Maciejewski","year":"2002","unstructured":"Maciejewski JP, Risitano A, Sloand EM, Nunez O, Young NS (2002) Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood 99:3129\u20133135. https:\/\/doi.org\/10.1182\/blood.v99.9.3129","journal-title":"Blood"},{"key":"6393_CR41","doi-asserted-by":"publisher","first-page":"2204617","DOI":"10.1080\/16078454.2023.2204617","volume":"28","author":"J Li","year":"2023","unstructured":"Li J, Li X, Cai L, Peng X, Yao M, Li S, Zhang G (2023) Prognostic value of pre-treatment PNH clone among the patients with aplasticanemia: a meta-analysis. Hematology 28:2204617. https:\/\/doi.org\/10.1080\/16078454.2023.2204617","journal-title":"Hematology"},{"key":"6393_CR42","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/ajh.25592","volume":"94","author":"G Zheng","year":"2019","unstructured":"Zheng G, Chen P, Pallavajjalla A, Haley L, Gondek L, Dezern A, Ling H, De Marchi F, Lin MT, Gocke C (2019) The diagnostic utility of targeted gene panel sequencing in discriminating etiologies of cytopenia. Am J Hematol 94:1141\u20131148. https:\/\/doi.org\/10.1002\/ajh.25592","journal-title":"Am J Hematol"},{"key":"6393_CR43","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1182\/blood-2017-07-794362","volume":"130","author":"JN Cooper","year":"2017","unstructured":"Cooper JN, Young NS (2017) Clonality in context: hematopoietic clones in their marrow environment. Blood 130:2363\u20132372. https:\/\/doi.org\/10.1182\/blood-2017-07-794362","journal-title":"Blood"},{"key":"6393_CR44","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/bjh.15443","volume":"182","author":"L Luzzatto","year":"2018","unstructured":"Luzzatto L, Risitano AM (2018) Advances in Understanding the pathogenesis of acquired aplastic anaemia. Br J Haematol 182:758\u2013776. https:\/\/doi.org\/10.1111\/bjh.15443","journal-title":"Br J Haematol"},{"key":"6393_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1182\/asheducation-2017.1.66","volume":"2017","author":"JP Maciejewski","year":"2017","unstructured":"Maciejewski JP, Balasubramanian SK (2017) Clinical implications of somatic mutations in aplastic anemia and myelodysplastic syndrome in genomic age. Hematol Am Soc Hematol Educ Program 2017:66\u201372. https:\/\/doi.org\/10.1182\/asheducation-2017.1.66","journal-title":"Hematol Am Soc Hematol Educ Program"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06393-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06393-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06393-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T07:48:45Z","timestamp":1757663325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06393-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6393"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06393-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Science, approved this study, adhering to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided written informed consent before the study commenced.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"No material from other sources has been reproduced in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}